期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 13, 期 7, 页码 8379-8387出版社
MDPI
DOI: 10.3390/ijms13078379
关键词
Astragalus membranaceus; advanced glycation end products; macrophage; inflammation; diabetes
资金
- Major State Basic Research Development Program of China (973 Program) [2012CB517700]
- Science and Technology Commission of Shanghai Municipality [10JC1413000]
- National Natural Science Foundation of China [30871175]
Advanced glycation end products (AGEs) and inflammation contribute to the development of diabetic complications. Astragalus membranaceus has properties of immunological regulation in many diseases. The aim of this study was to determine the function of A. membranaceus extract (AME) on the AGE-induced inflammatory response in Ana-1 macrophages. The viability of cells treated with AME or AGEs was evaluated with the MTT [3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide] method. The secretion and mRNA levels of IL-1 beta and TNF-alpha were measured by ELISA and RT-PCR, respectively. The activity of NF-kappa B was assayed by EMSA. The phosphorylation of p38 MAPK was assessed by western blotting. The results showed that AME was not toxic to macrophages. The treatment of macrophages with AME effectively inhibited AGE-induced IL-1 beta and TNF-alpha secretion and mRNA expression in macrophages. These effects may be mediated by p38 MAPK and the NF-kappa B pathway. The results suggest that AME can inhibit AGE-induced inflammatory cytokine production to down-regulate macrophage-mediated inflammation via p38 MAPK and NF-kappa B signaling pathways and indicate that AME could be an immunoregulatory agent against AGE-induced inflammation in diabetes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据